Listeriosis results from exposure to the foodborne pathogen Listeria monocytogenes. Although many different strains of L. monocytogenes are isolated from food, no definitive tests currently predict which isolates are most virulent. The objectives of this study were to address two major data gaps for risk assessors, variability among L. monocytogenes strains in pathogenicity and virulence. Strains used in our monkey clinical trial or additional food isolates were evaluated for their virulence and infectivity in mice. All strains were equally pathogenic to immunocompromised mice, causing deaths to 50% of the population 3 days after exposure to doses ranging from 2 to 3 log CFU. Doses resulting in 50% deaths on the fifth day after administration were I to 2 log lower than those on the third day, indicating that the full course of pathogenicity exceeds the 3-day endpoint in immunocompromised mice. Three strains were chosen for further testing for their virulence and infectivity in liver and spleen in normal (immunocompetent) mice. Virulence was not significantly different (P > 0.05) among the three strains, all resulting in deaths to 50% of mice at 5 to 7 log CFU by 5 days after administration. All strains were equally infective in liver or spleen, with higher numbers of L. monocytogenes directly correlated with higher doses of administration. In addition, there was no preference of organs by any strains. The lack of strain differences may reflect the limitation of the mouse model and suggests the importance of using various models to evaluate the pathogenicity and virulence of L. nwnocytogenes strains.
The Centers for Disease Control and Prevention, based on active surveillance from 2000, estimates that approximately 2,500 people in the United States become ill annually from foodborne Listeria monucyto genes, and approximately 500 die (6) . The consumption of contaminated ready-to-eat foods is considered to be the principal route of L. monocytogenes infection. Soft cheese (3, 7, 19) , pasteurized milk (4) , and deli meats (5) have been associated with outbreaks of listenosis. Four serotypes (4b, 1/2a, 1/2b, and 1/2c) among 13 known serotypes have been isolated from a wide range of foods (12) . Three of these serotypes (4b, 1/2a and 1/2b) are associated with the majority of human listeriosis (12) .
Risk factors for infection are underlying illnesses, impaired immune system, extreme age, and pregnancy (12, 20) . In healthy individuals, infections are generally rare, sporadic, and mild, with symptoms characterized as flu-like (12, 19, 20) . However, the outcome of listeriosis is serious in susceptible individuals, potentially leading to septicemia and meningitis (12, 19, 20) . In pregnant women, listeriosis primarily affects the fetus or neonate and can result in spontaneous abortion or stillbirth. Studies have linked listenosis to 1 to 6% of spontaneous abortions in western European countries (10) .
Because human trials for L. monocytogenes are unethical because of the potential fatal outcome for susceptible individuals, animal surrogate studies must be developed to describe dose-response relationships for various adverse endpoints and for extrapolation to human dose-response models. Nonhuman primates have been used for dose-response studies (11, 28) , but the cost and limited numbers of primates per dose group make the use of nonhuman primates for L. monocytogenes strain comparisons prohibitive. The objective of our study was to screen a panel of L. monocytogenes strains for pathogenicity and invasion of the liver and spleen in mice. The panel included strains used in a primate study (28) and additional strains isolated from food linked to human illness (5, 13, 27) .
The mouse is the most commonly used species for the study of L. monocytogenes, and there are numerous publications on the pathogenicity, virulence, infectivity, genetic factors, and other characteristics of different L. monocytogenes strains. However, many studies use three or fewer strains and cannot be directly compared to other studies because of differences in strains used, animal models used for testing, or interlaboratory methods. Results obtained in this study provide information on virulence that can aid in direct comparisons of L. monocytogenes strains that are known human or primate pathogens and three food isolates. Additionally, we knew little about the virulence of the nonhuman primate clinical isolate, strain 12443, which we used in our pregnant nonhuman primate model (28) , and this 
MATERIALS AND METHODS
Mice. Female ICR mice, 18 to 20 g, were obtained from Harlan Sprague Dawley (Indianapolis, Ind.). Mice were housed in groups of five in cages covered by wire lids and filters with free access to sterile food and water. The mice were held under these conditions for 24 h before the study began and throughout the study period. All animals used in this study were handled in accordance with National Institutes of Health guidelines, and their use was approved by the University of Georgia Institutional Animal Use and Care Committee.
Bacterial strains and preparation of inocula. The L. monocyro genes strains used in this study included several from our nonhuman primate study (human clinical isolates Scott A, G3982, G3990, and 1-17550 and monkey clinical isolates 12443 and 12375) (28) in addition to three foodborne isolates (I01M, beefpork sausage (13); F6854, turkey frankfurter (27) ; and H7776, frankfurter (5)) provided by the U.S. Department of Agriculture. Agricultural Research Service (USDA-ARS), Wyndmoor, Pa. (Table 1). Cultures were stored on latex beads at -80°C. Cultures were grown during three successive overnight transfers at 37°C in tryptic soy broth (Difco, Becton Dickinson, Sparks, Md.). Cells were washed twice with 0.01 M potassium phosphate-buffered saline (PBS; pH 7.2) by centrifugation (3,500 X g) for 10 min at room temperature, sedimented in a final wash, and then resuspended in PBS. Cell numbers in suspensions were determined by surface plating serial dilutions (1:10) on tryptic soy agar (Difco, Becton Dickinson) in duplicate. Colonies were enumerated after 24 h of incubation at 37°C. Inocula were prepared by diluting cell suspensions serially (1:10) in PBS. 
monocytogenes H9666 and
Listeria inn ocua were used as positive and negative controls, respectively. Strain 1-19666 was previously tested in our laboratory and found to infect both immunocompromised and normal mice (30) . Control mice were administered 0.1 ml of sterile PBS i.p. Mice were observed for death three times daily for 5 days. Any signs of illnesses, such as ruffled fur and lethargy (lack of movement), were also recorded. Isolates that caused at least one death within 5 days were designated as pathogenic (16) . Strains that did not cause death within 5 days were designated as nonpathogenic.
Evaluation of dose response. The effect of different doses on mice was determined for L. inonocyro genes strains that were pathogenic to iminunocompromised mice. Mice were immunocompromised as previously described. Five concentrations of each L. monocyro genes strain were prepared as described above and inoculated in mice (five mice per concentration). Concentrations administered were based on the outcome of the pathogenicity screening test. Control mice were given 0.1 ml of sterile 0.01 M potassium PBS (pH 7.2). L. monocytogenes H9666 and L. innocua were inoculated in mice to serve as positive (virulent) and negative (nonvirulent) controls, respectively. Mice were observed for death three times a day for 5 days. The method of Reed and Muench (26) was used to estimate doses that resulted in the death of 50% of mice. When 50% of deaths occurred outside the range of the dose tested, the 50% lethal dose (LD 50) was determined by extrapolation.
Infectivity determination. L. monocytogenes inocula of pathogenic strains were prepared as described above. Based on results of the pathogenicity experiment, one concentration that resulted in consistent death of the mice was selected for the evaluation of infection of liver and spleen. Three L. m000cytogenes strains were inoculated i.p. in normal (immunocompetent) mice. A known virulent strain of L. monocyto genes (H9666) and a nonvirulent strain (L. innocua) were used as positive and negative controls, respectively. Control mice were injected with PBS. Based on preliminary experiments and previous work in our laboratory (30), necropsy dates were selected. Mice were euthanized by carbon dioxide asphyxiation, and necropsy was performed. Livers and spleens were aseptically removed from mice, weighed, and macerated in PBS. The tissue suspensions were serially diluted in PBS and surface plated on tryptic soy agar in duplicate to determine the bacterial counts in each organ. Plates were incubated at 37°C for 24 h prior to enumeration. Colonies were examined for typical Listeria appearance by Henry illumination. Select colonies were confirmed as L. monocyro genes by standard tests (12, 16) . In addition, pulsed-field gel electrophoresis (PFGE) patterns of isolates from tissue were compared with the strains used for inoculation to determine the stability of the original strains during passage through the mouse. PFGE (15) was performed using AscI as a restriction enzyme and L. monocvtogenes strain H2446, which produces 14 bands with AscI, as a standard.
Statistical analysis. Data were analyzed statistically by analysis of variance and Duncan's multiple range test using Statistical Analysis Software (version 6.12. SAS, Cary, N.C.) at 5% level of significance. monocyto genes strains tested.
RESULTS

Assessment
diarrhea and rapid and shallow breathing, and then died or were humanely euthanized. Most deaths occurred by the fourth day after inoculation with L. monocytogenes strains. Some mice that developed roughness on their coats never progressed into a lethargic state and recovered from the infection. The doses resulting in deaths in 50% of inoculated immunocompromised mice 3 and 5 days after administration are shown in Table 2 . Test strains did not significantly differ in LD50 values (P > 0.05) on either the third or fifth day postadministration. On posttreatment day 3. LD50 doses for immunocompromised mice ranged from approximately 4 to 6 log CFU per mouse. On posttreatment day 5, the estimates of LD 50 were reduced by 1 to 2 log CFU. The L. monocytogenes strains having the highest and lowest LD 50 in immunocompromised mice (12443 and G3982, respectively), strain H9666 (pathogenic control), and L. innocua (nonpathogenic control) were further tested in normal (immunocompetent) mice. Although all L. monocytogenes strains, except the nonpathogenic control L. innocua, resulted in death in normal mice, there were no significant differences (P> 0.05) in virulence (based on LD50) among L. monocytogenes strains for the experimental conditions tested. However, there was a significant difference (P < 0.05) when comparing the third and fifth day LD50 in normal mice for all three strains. H9666 (pathogenic control), G3982, and 12443 required approximately 7 log CFU for death to result in 50% of mice on the third day and 4 to 5 log CFU on the fifth day (Table 3 ). For all strains tested, a higher dose of L. monocytogenes was consistently required to cause deaths in normal mice compared with immunoconipromised mice; however, statistical comparisons of doses between the two groups were not done.
The invasion and persistence of each strain in the liver and spleen was evaluated in normal mice for two L. monocvtogenes test strains, 12443 and G3982, and pathogenic and nonpathogenic controls, L. monocyto genes H9666 and L. innocua (Figs. 1 and 2 ). There were no significant dif- Selected colonies from each treated group of mice were tested by PFGE analysis for quality control. PFGE patterns were identical to the treatment strains in all cases. This result provides evidence of the stability of the genetic structure, at the level of PFGE sensitivity, of the strains during the course of infection and verifies that the recovered strain was the same as the treatment strain and not from a contaminating source.
DISCUSSION
All L. monocyfogenes strains tested in our study, except the negative control strain L. innocua, were pathogenic to immunocompromised mice regardless of the source. The LD50 doses determined in the study were comparable to those observed in other studies using i.p. injection (1, 8, 21, 25) . However, the differences in virulence among strains reported by other researchers were not observed in our study (21, 25, 29) . Barbour et al. (2) has shown that intravenous injections (i.v.) result in lower LD 50 estimates in mice than intragastric exposures. This result is expected because i.v. injection bypasses host defense mechanisms that normally constrain progression of disease from oral exposure routes. For the same reasons, differences may also be expected for LD 50 estimates from i.p. injections compared with oral infection (17) . The increased dose of L. monocvtogenes strains required to cause deaths in 50% of normal (immunocompetent) mice as compared with immunocompromised mice confirms that impaired immunity increases the risk of listeriosis (29) . However, in our study, pathogenesis in both normal and immunocompromised mice appears to require more than 3 days for full development based on the significantly lower (P < 0.05) LD50
at five days posttreatment compared with 3 days posttreatment (Tables 2 and 3) . In a normal course of infection by L. monocytogenes from foods, the organism will enter the host through epithelial cells in the intestinal tract (9, 22) . Once inside the host cell, L. monocvtogenes can evade cell-mediated immunity, multiply in the cytoplasm, and migrate toward the cell periphery to invade macrophages and enter the lymphatics and lymph nodes. At this point, L. tnonocytogenes can enter the bloodstream and further disseminate to tissues such as liver and spleen. The extent of invasion was previously related to the virulence of strains (2, 23) . In our study, we recovered similar levels (CFU) of all three strains from liver and spleen of normal mice. These results are not surprising because there was no significant difference (P > 0.05) in doses required to cause deaths in 50% of mice. However, higher rates of invasion observed at higher levels of inoculum provide evidence of dose dependency for severity of listeriosis regardless of strain. Such a mechanism suggests that a high dose of pathogens may overwhelm the host defenses, resulting in an increased likelihood that a fraction of the pathogen dose successfully evades the host immune defenses, survives to invade host tissues, and replicates in host tissues to the magnitude necessary to cause severe damage. In contrast, this mechanism of density-dependent severity suggests that tow dose challenges may be effectively eliminated by host defenses prior to significant tissue damage.
In our study, as in others, invasion of liver and spleen was also observed with nonpathogenic L. innocua. Menudier et al. (23) observed infection of spleen and liver in 5 and 10% of mice at 0.13 and 0.24 log CFU/g of organ, respectively, after exposure to 106 CFU L. innocua by the i.p. route of exposure. von Koenig et al. (31) has also demonstrated that L. innocua can enter the spleen at approximately 4 log CFU per spleen when mice are i.p. infected at 9 log CFU, although L. innocua was incapable of growing in the spleen and steadily decreased in numbers with time. After 3 days postinoculation, the numbers decreased to approximately 2 log CFU per spleen and became undetectable after 6 days (31). Our observed rates and levels of infection of liver and spleen by L. innocua were higher than these observations. Differences in susceptibility to listenosis among different mouse strains has been demonstrated (14, 21) and may account for the differences in our results from previous studies.
Golnazarian et al. (14) used hydrocortisone acetate or cimetidine to immunocompromise mice and subsequently i.p. injected mice with L. nonocvtogenes strains in doses ranging from 1.0 to 7.0 log CFUImI. In our study, we used carrageenan to immunocompromise mice and 24 h later injected L. monocytogenes in doses ranging from I to 7 log CFU/inl. Carrageenan was selected as the macrophage-suppressing agent because of its ability to cause an eightfold decrease in the number of macrophages in mouse peripheral blood within 2 days and because of its long-lasting effect, with full recovery requiring 15 days (29) . Cortisone acetate has also been shown to suppress cellular immunity and to increase the susceptibility of mice to Listeria infection (14, 24) . However, cortisone acetate's effect wanes rapidly after 24 h (24), indicating that it would probably not be effective for the duration of the infection. Golnazarian et al. (14) reported LD 50 results from i.p. injected mice ranging from 3 to 6 log CFU/ml. Other reported values for the LD50 of L. monocytogenes in mice range from 3 to 10 log CFU, depending on the strain of Lisreria, the strain of mouse, and the route of inoculation (1, 14) . In order for valid inferences to be drawn from the diverse reports of LD 5() from various mouse models to predict likelihood and severity of adverse effects in humans, a conceptual model is needed that elucidates the controlling events of pathogenesis for scaling within and between host species.
The difficulty of using animal models to study the mechanisms of pathogenicity and virulence of L. monocytogenes to understand human listeriosis has been recognized by several researchers. One example is recent evidence for the role of internalin for L. monocytogenes invasion of human epithelial cells. Mouse E-cadherin is not a receptor for internalin as it is in humans (18) . Other factors may also be different between mouse and human usteriosis. In addition, different methods of administration of L. monocytogenes may result in different outcomes due to changes in the course of infection. Our study demonstrates the importance of evaluating the pathogenicity and virulence of L. monocytogenes strains in multiple animal models to expand knowledge of the mechanisms of listeriosis and enable more rigorous scientific inferences to build defensible dose-response models for human listeriosis.
